FLUOROURACIL Accord sol inj 250 mg/5ml 5 ml
7680668250011
CH-66825
L01BC02
07.16.1.
1 / 3
google
Details
- Product number
- 6682501
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- fluorouracilum 250 mg, natrii hydroxidum corresp. natrium 41.24 mg, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml.
Articles (1)
Fluorouracil Accord 250 mg/5 ml, Injektions-/Infusionslösung
Injektions-/Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
250.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
41.24 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 12.40
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2018
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 66825
- Drug name
- Fluorouracil Accord, Injektions-/Infusionslösung
- Galenic form
- LSIN
- ATC Code
- L01BC02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 15/08/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- FLUOROURACIL Accord sol inj 250 mg/5ml 5 ml
- Description (DE)
- FLUOROURACIL Accord Inj Lös 250 mg/5ml 5 ml
- Market launch
- 15/08/2018
- Narcotic (BTM)
- No